A new study will be launched in Britain to research the efficacy of coronavirus vaccines in people with low immunity due to health conditions, including cancer, local media reported.
In the Octave study, up to 5,000 of these patients, from around Britain, will be vaccinated as part of the country's mass rollout, the BBC reported on 3 March, Wednesday.
"The Octave study will give us invaluable new data to help us answer questions of this kind from our patients and their families," said the statement.
More than 20.4 million people in Britain have been given the first jab of the coronavirus vaccine, according to the latest official figures.
On 22 February, British Prime Minister Boris Johnson announced his long-anticipated "roadmap" exiting the lockdown. Schools in England will reopen from March 8 as the first part of the four-step plan, which Johnson said was designed to be "cautious but irreversible".
(This story was published from a syndicated feed. Only the headline and picture has been edited by FIT).
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)